학술논문

Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor-1 inhibitor TM5614 combined with a tyrosine kinase inhibitor
Document Type
Journal
Source
CANCER MEDICINE; SEP 23 2022, 9p.
Subject
Language
English
ISSN
20457634